ClinicalTrials.Veeva

Menu

Cerebral and Cognitive Markers of Treatment Resistance in Obsessive Compulsive Disorder (3TOC)

C

Centre Hospitalier Henri Laborit

Status

Enrolling

Conditions

OCD

Treatments

Other: Functional MRI

Study type

Observational

Funder types

Other

Identifiers

NCT05843604
2022-A00463-40

Details and patient eligibility

About

This study aims to define individual profiles of treatment resistants in order to find indicators and predictors of the therapeutic response.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Obsessive compulsive disorder diagnosed according to Diagnostic and Statistical Manual 5 criteria (patients will be included regardless of the severity and resistance of their pathology and their levels of executive functions)
  • Understand and accept the constraints of the study
  • Be a beneficiary or affiliated to a Health Insurance scheme

Exclusion criteria

  • Present one of the diagnoses according to the criteria of the DSM 5: schizophrenic disorders, substance abuse or dependence to a substance according to the criteria of the M.I.N.I. version 5.0 (Sheehan et al., 1998)
  • Generalized anxiety disorder, social anxiety, nicotine dependence and history of a major depressive episode are not exclusion criteria according to the M.I.N.I. version 5.0 (Sheehan et al., 1998)
  • Have a serious intercurrent pathology
  • Being a pregnant woman
  • Being a woman of childbearing age without effective contraception.
  • Being hospitalized under duress or on an outpatient basis in a care program
  • Being under judicial protection (reinforced curatorship, guardianship)

Trial design

100 participants in 2 patient groups

obsessive compulsive disorder patients
Treatment:
Other: Functional MRI
Control Patients
Treatment:
Other: Functional MRI

Trial contacts and locations

1

Loading...

Central trial contact

Damien Doolub, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems